Aclaris Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aclaris Therapeutics

07/08/2024 14:00

* Aclaris Therapeutics Inc  ACRS.OQ  reported a quarterly
adjusted
loss of 15 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -42 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 20 cents per
share. Wall Street expected results to range from -34 cents
to -12 cents per share.
    * Revenue rose 48% to $2.77 million from a year ago;
analysts
expected $1.82 million. 
    * Aclaris Therapeutics Inc's reported EPS for the quarter
was a
loss of 15 cents​.
    * The company reported a quarterly loss of $10.99 million.
    * Aclaris Therapeutics Inc shares had risen by 10.9% this
quarter and gained 16.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Aclaris
Therapeutics Inc is $1.60 
This summary was machine generated from LSEG data August 7 at
01:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.20          -0.15          Beat
 Mar. 31 2024      -0.29          -0.24          Beat
 Dec. 31 2023      -0.34          -0.02          Beat
 Sep. 30 2023      -0.48          -0.41          Beat